107 related articles for article (PubMed ID: 3125389)
21. Influence of anti-slime glycolipoprotein serum on the interaction between Pseudomonas aeruginosa and macrophages.
Bartell PF; Krikszens A
Infect Immun; 1980 Mar; 27(3):777-83. PubMed ID: 6769808
[TBL] [Abstract][Full Text] [Related]
22. Opsonic and complement-dependent bactericidal activities of various immunoglobulin preparations for intravenous use.
Yasuda H; Yajima T; Tanii T; Ashiba T; Iwata M
Vox Sang; 1986; 51(4):270-7. PubMed ID: 3099470
[TBL] [Abstract][Full Text] [Related]
23. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b.
Amir J; Scott MG; Nahm MH; Granoff DM
J Infect Dis; 1990 Jul; 162(1):163-71. PubMed ID: 2355193
[TBL] [Abstract][Full Text] [Related]
24. Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.
Milatovic D
Eur J Clin Microbiol; 1984 Aug; 3(4):288-93. PubMed ID: 6436020
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.
Pier GB; Thomas D; Small G; Siadak A; Zweerink H
Infect Immun; 1989 Jan; 57(1):174-9. PubMed ID: 2491835
[TBL] [Abstract][Full Text] [Related]
26. Opsonophagocytosis of Pneumocystis carinii.
Taylor MB; Phillips M; Easmon CS
J Med Microbiol; 1992 Apr; 36(4):223-8. PubMed ID: 1560444
[TBL] [Abstract][Full Text] [Related]
27. An Opsonophagocytic Killing Assay for the Evaluation of Group A Streptococcus Vaccine Antisera.
McGregor R; Jones S; Jeremy RM; Goldblatt D; Moreland NJ
Methods Mol Biol; 2020; 2136():323-335. PubMed ID: 32430834
[TBL] [Abstract][Full Text] [Related]
28. [Effect of Pseudomonas immunoglobulin on the antibacterial activity of human phagocytes].
Just HM; Termöhlen M; Pinkawa M; Daschner FD
Infection; 1987; 15 Suppl 2():S42-6. PubMed ID: 3112019
[TBL] [Abstract][Full Text] [Related]
29. Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.
Naess LM; Aarvak T; Aase A; Oftung F; Høiby EA; Sandin R; Michaelsen TE
Vaccine; 1999 Feb; 17(7-8):754-64. PubMed ID: 10067680
[TBL] [Abstract][Full Text] [Related]
30. [Effect of Pseudomonas immunoglobulin on the antibacterial activity of human phagocytes].
Just HM; Termöhlen M; Pinkawa M; Daschner FD
Infection; 1987; 15(1):51-5. PubMed ID: 3106229
[TBL] [Abstract][Full Text] [Related]
31. Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors.
Gordon DL; Rice JL
Immunology; 1988 Aug; 64(4):709-14. PubMed ID: 2971611
[TBL] [Abstract][Full Text] [Related]
32. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.
Edwards MS; Baker CJ; Kasper DL
J Infect Dis; 1979 Dec; 140(6):1004-8. PubMed ID: 396335
[TBL] [Abstract][Full Text] [Related]
33. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
34. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
Lieberman MM
Antibiot Chemother (1971); 1989; 42():193-202. PubMed ID: 2512837
[No Abstract] [Full Text] [Related]
35. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa.
McCormick LL; Karulin AY; Schreiber JR; Greenspan NS
J Immunol; 1997 Apr; 158(7):3474-82. PubMed ID: 9120309
[TBL] [Abstract][Full Text] [Related]
36. Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice.
Nakamura S; Iwanaga N; Seki M; Fukudome K; Oshima K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Mukae H; Kohno S
Infect Immun; 2016 Jul; 84(7):1986-1993. PubMed ID: 27091927
[TBL] [Abstract][Full Text] [Related]
37. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.
Young LS; Armstrong D
J Infect Dis; 1972 Sep; 126(3):257-76. PubMed ID: 4626509
[No Abstract] [Full Text] [Related]
38. Bactericidal effect of polymorphonuclear leukocytes on Pseudomonas aeruginosa pre-incubated in ofloxacin.
Nielsen B; Nielsen H
Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):227-32. PubMed ID: 3118637
[TBL] [Abstract][Full Text] [Related]
39. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
Lieberman MM; Ayala E
J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
[No Abstract] [Full Text] [Related]
40. Resistance of Pasteurella multocida to rabbit neutrophil phagocytosis and killing.
Rush HG; Glorioso JC; DaRif CA; Olson LC
Am J Vet Res; 1981 Oct; 42(10):1760-8. PubMed ID: 7325438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
